Last updated: April 19, 2024
Sponsor: Helwan University
Overall Status: Active - Recruiting
Phase
3
Condition
Arrhythmia
Chest Pain
Cardiac Disease
Treatment
Sodium Chloride 0.9% Inj
Calcium Chloride
Clinical Study ID
NCT06378021
Calcium chloride in CABG
Ages 18-74 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Patients more than 18 years old 2 ) patients undergoing On pump CABG
Exclusion
Exclusion Criteria:
- patients >75 years of age
- Patients with Pre operative Atrial fibrillation
- Patients with Significant valvular disease
- Ejection fraction <30% 6. Combined surgery of any kind 7. Congenital heart disease 8.Abnormal severe liver or kidney dysfunction. 9. Patients undergoing Off-pump CABG 10.Poorly controlled hyperthyroidism 11. Refusal to enrollment.
Study Design
Total Participants: 100
Treatment Group(s): 2
Primary Treatment: Sodium Chloride 0.9% Inj
Phase: 3
Study Start date:
March 14, 2024
Estimated Completion Date:
April 30, 2025
Study Description
Connect with a study center
Ain shams university
Cairo, Abassia Cairo 02
EgyptActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.